Covered recipient · General Payments record
RODOMELLE C MUNGCAL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$858.23
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.98 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amylyx Pharmaceuticals, Inc. | $118.23 | 1 |
| GlaxoSmithKline, LLC. | $60.75 | 3 |
| Novo Nordisk AS | $46.11 | 2 |
| Merck Sharp & Dohme Corporation | $45.52 | 2 |
| Amgen Inc. | $35.91 | 2 |
| ABBVIE INC. | $27.36 | 1 |
| Lilly USA, LLC | $25.07 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.36 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105081967 | CMS |
| Amgen Inc. | $17.37 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115951761 | CMS |
| Amgen Inc. | $18.54 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117636173 | CMS |
| Amylyx Pharmaceuticals, Inc. | $118.23 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148254309 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.03 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118103973 | CMS |
| GlaxoSmithKline, LLC. | $19.89 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116287846 | CMS |
| GlaxoSmithKline, LLC. | $13.23 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116715213 | CMS |
| GlaxoSmithKline, LLC. | $27.63 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116474854 | CMS |
| Lilly USA, LLC | $25.07 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373110 | CMS |
| Merck Sharp & Dohme LLC | $21.20 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141905668 | CMS |
| Merck Sharp & Dohme LLC | $24.32 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141809590 | CMS |
| Novo Nordisk Inc | $23.33 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096877970 | CMS |
| Novo Nordisk Inc | $22.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097756845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.